Tirzepatide is a dual-action agonist for GLP-1 and GIP receptors, intended solely for research purposes. Its robust combination of receptor activity has demonstrated encouraging outcomes in studies focused on weight loss and metabolic health.
Offered in 10mg, 20mg, and 30mg doses, Tirzepatide presents an innovative solution for researchers investigating advanced strategies for metabolic health and weight loss.
Key Benefits:
- For research purposes only
- Dual-action mechanism (GLP-1 and GIP) to enhance metabolic effects
- Available in 10mg, 20mg, and 30mg doses for versatile research
- Perfect for advanced studies on weight loss and metabolic health
- (includes free injection pen)
